FDA requests removal of Opana ER for risks related to abuse

by Karl Voigt

Patients who are taking the pain medication Opana are now facing its manufacturer’s withdrawal of the medication from the market.

Earler this year, the US Food and Drug Administration (FDA) concluded that Opana ER “exposes patients and other users to the risks of opioid addiction, abuse, and misuse, which can lead to overdose and death”. The drug has been available since 2006.

The manufacturer, Endo Pharmaceuticals based in Malvern PA, has been withdrawing the medication from pharmacies since June. Supplies are nearly gone and patients should consult with their physicians for a suitable alternative.

The FDA has made no secret that they intend to review other opioid painkillers.


One thought on “FDA requests removal of Opana ER for risks related to abuse

  1. Typical drug abuse reaction from the government. People misuse (Crush an extended release pill, inject it, etc.) a drug that is NOT as it is prescribed.
    So they yank it off the market, or restrict it so much almost no one can get it any more.
    Also I’ve heard stories of it being prescribed inappropriately too. That’s a powerful drug, giving it as the first or second drug after an injury or surgery is NOT a smart idea. It’s a moot point now, the drug is disappearing off the market.


Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s